<p>Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, agitation associated with dementia due to Alzheimer’s disease, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, as well as multiple novel product candidates addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain’s biggest problems so patients and their loved ones can flourish. For more information, please visit us at <a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DQQIa-gYpjh8WDA8s-h_cxtiLRzsSWm9ZOooeS2xh8kY8-FumfaVAL8G_hC6J6y6LuXKTBTKoXqd1vp9_5M907w%3D%3D&data=05%7C02%7Cmgottlieb%40axsome.com%7C94b768d338984742b95108deb1b8bf59%7Cb3096ec47bba4e2f9c92818dea8094e1%7C0%7C0%7C639143604215603530%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C4000%7C%7C%7C&sdata=TjWpZh6IDBHgXJdRYV0jlpcIhO1%2Fgb%2BwvqZkNTQHwT4%3D&reserved=0"><strong>www.axsome.com</strong></a> and follow us on <a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3D_1y-uBUKIw3KWJ6Y-geQ15plDCyHIG7Py7UrynaLe_a3Ox38W8ZNivhkg6dSO_EWMIT6bNTFwzm046vzW_oTZatsU1_U7o9NHovDE-a03JE%3D&data=05%7C02%7Cmgottlieb%40axsome.com%7C94b768d338984742b95108deb1b8bf59%7Cb3096ec47bba4e2f9c92818dea8094e1%7C0%7C0%7C639143604215672478%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C4000%7C%7C%7C&sdata=FaIerB3ydvNMCjbtbD8GFKfpnS8a2dr%2F6FGtoflsxn4%3D&reserved=0"><strong>LinkedIn</strong></a> and <a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DF1-pkxXL1lZ12X8uiqEChktKQU5vuDQzzM1QTwq95wNWfa9_p27EwyIBpUngNstn&data=05%7C02%7Cmgottlieb%40axsome.com%7C94b768d338984742b95108deb1b8bf59%7Cb3096ec47bba4e2f9c92818dea8094e1%7C0%7C0%7C639143604215702635%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C4000%7C%7C%7C&sdata=2nBwhiP0X55i4MMCaSXQ5MchbHQh2zeZUEIzp3BYefw%3D&reserved=0"><strong>X</strong></a>.</p> <p><strong>About This Role</strong></p> <p><span data-contrast="none"><span data-ccp-parastyle="Body Text">Axsome</span><span data-ccp-parastyle="Body Text"> Therapeutics is currently searching for a</span><span data-ccp-parastyle="Body Text"> field based</span><span data-ccp-parastyle="Body Text"> </span><span data-ccp-parastyle="Body Text">Long-Term Care (LTC)</span><span data-ccp-parastyle="Body Text"> </span><span data-ccp-parastyle="Body Text">Key</span><span data-ccp-parastyle="Body Text"> Account Manager </span><span data-ccp-parastyle="Body Text">(</span><span data-ccp-parastyle="Body Text">K</span><span data-ccp-parastyle="Body Text">AM</span><span data-ccp-parastyle="Body Text">)</span><span data-ccp-parastyle="Body Text">, </span><span data-ccp-parastyle="Body Text">to </span><span data-ccp-parastyle="Body Text">drive</span><span data-ccp-parastyle="Body Text"> </span><span data-ccp-parastyle="Body Text">LTC </span><span data-ccp-parastyle="Body Text">commercial activities for </span><span data-ccp-parastyle="Body Text">assigned</span><span data-ccp-parastyle="Body Text"> geograph</span><span data-ccp-parastyle="Body Text">ies</span><span data-ccp-parastyle="Body Text"> </span><span data-ccp-parastyle="Body Text">in accordance with</span><span data-ccp-parastyle="Body Text"> sales and </span><span data-ccp-parastyle="Body Text">marketing strategies</span><span data-ccp-parastyle="Body Text">. The LTC KAM will </span><span data-ccp-parastyle="Body Text">be responsible for</span><span data-ccp-parastyle="Body Text"> building </span><span data-ccp-parastyle="Body Text">brand and company </span><span data-ccp-parastyle="Body Text">awareness </span><span data-ccp-parastyle="Body Text">while </span><span data-ccp-parastyle="Body Text">supporting product adoption </span><span data-ccp-parastyle="Body Text">across approved </span><span data-ccp-parastyle="Body Text">indications. </span></span><span data-ccp-props="{"134245417":false,"201341983":0,"335559685":0,"335559731":0,"335559738":182,"335559739":0,"335559740":240,"335559991":360}"> </span></p> <p><span data-contrast="auto"><span data-ccp-parastyle="Body Text">The </span><span data-ccp-parastyle="Body Text">LTC KAM</span><span data-ccp-parastyle="Body Text"> </span><span data-ccp-parastyle="Body Text">is responsible for</span><span data-ccp-parastyle="Body Text"> developing and executing strategic business plans across regional and national </span><span data-ccp-paras